Cell-based therapeutic strategies for multiple sclerosis

The availability of multiple disease-modifying medications with regulatory approval to treat multiple sclerosis illustrates the substantial progress made in therapy of the disease. However, all are only partially effective in preventing inflammatory tissue damage in the central nervous system and no...

Descripción completa

Detalles Bibliográficos
Autores principales: Scolding, Neil J, Pasquini, Marcelo, Reingold, Stephen C, Cohen, Jeffrey A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841198/
https://www.ncbi.nlm.nih.gov/pubmed/29053779
http://dx.doi.org/10.1093/brain/awx154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841198/
https://www.ncbi.nlm.nih.gov/pubmed/29053779
http://dx.doi.org/10.1093/brain/awx154

Ejemplares similares